ICICI Bank’s board will consider unaudited standalone and consolidated results for the quarter and six months ending September 30, 2026, at a meeting on October 17. Investors have a scheduled date for the results review, while designated persons and their relatives face a securities trading restriction through October 19.
Key Highlights
- ICICI Bank’s board is scheduled to review unaudited standalone and consolidated results on October 17, 2026.
- Trading in the bank’s securities is restricted for designated persons and immediate relatives from October 1 through October 19, 2026.
- Board meeting scheduled for October 17 to consider unaudited results.
- Standalone and consolidated results for periods ending September 30 will be reviewed.
October 17 Results Review
The board’s agenda includes approval of the two sets of unaudited results for the periods ending September 30. The standalone statements will be considered alongside the consolidated statements. The scheduled meeting gives the results process a specific date. Prachiti D. Lalingkar signed the announcement for ICICI Bank (NYSE: IBN) on September 22, 2026, using the title Company Secretary.
Trading Window Closed Through October 19
A restriction on dealing in ICICI Bank securities applies to all designated persons, including directors, and their immediate relatives. The closed period begins on October 1, 2026, and ends on October 19, 2026, with both dates included.
FAQs
Q: When will ICICI Bank review its September 30 financial results?
A: ICICI Bank’s board is scheduled to consider the unaudited financial results on October 17, 2026.
Q: When is ICICI Bank’s trading window closed?
A: Trading in ICICI Bank securities is restricted from October 1 through October 19, 2026. The closure applies to designated persons, directors and their immediate relatives.
Q: Which ICICI Bank results will the board consider?
A: The board will consider unaudited standalone and consolidated financial results.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.